Welcome to our dedicated page for CME Group news (Ticker: CME), a resource for investors and traders seeking the latest updates and insights on CME Group stock.
CME Group Inc. (NASDAQ: CME) operates the world's leading derivatives marketplace, providing essential tools for global risk management through futures contracts, options trading, and clearing services. This news hub offers institutional investors, financial analysts, and commercial hedgers centralized access to critical updates shaping derivatives markets.
Track official announcements including quarterly earnings, product expansions like short-dated options, and strategic partnerships with entities such as S&P Dow Jones Indices. Our curated collection features regulatory filings, market infrastructure updates, and insights into key asset classes: interest rate derivatives, equity indexes, and agricultural commodities.
Discover time-sensitive information on CME Clearing's risk management protocols, CME Globex platform enhancements, and evolving ESG initiatives including carbon credit futures. This resource serves financial professionals requiring accurate, up-to-date intelligence for hedging strategies and market analysis.
Bookmark this page for continuous access to CME Group's latest developments in derivatives innovation, global market liquidity, and financial system stability. Verify critical dates for contract expirations and market holidays through official company communications.
CME Group (NASDAQ: CME) has announced the preliminary results of its 2025 annual shareholder meeting. Shareholders elected 14 directors including Terrence A. Duffy for one-year terms expiring in 2026. They also ratified Ernst & Young LLP as the company's independent auditor for 2025 and approved executive compensation on an advisory basis.
Due to lack of quorum in Class B director elections, incumbent Class B directors William W. Hobert, Patrick J. Mulchrone, Robert J. Tierney Jr. (Class B-1), Patrick W. Maloney (Class B-2), and Elizabeth A. Cook (Class B-3) will continue serving until the 2026 annual meeting.
CME Group (CME), the world's leading derivatives marketplace, has announced a quarterly dividend of $1.25 per share for the second quarter. The dividend will be payable on June 25, 2025, to shareholders of record as of June 9, 2025.
CME Group operates a comprehensive derivatives trading platform through CME Globex, offering futures and options trading across major asset classes including interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company also provides fixed income trading via BrokerTec, foreign exchange trading on the EBS platform, and operates CME Clearing, a leading central counterparty clearing provider.
The Purdue University/CME Group Ag Economy Barometer rose 8 points to 148 in April 2025, showing improved farmer sentiment. The Index of Current Conditions increased to 141 (+9 points) and the Index of Future Expectations climbed to 152 (+8 points). The Farm Capital Investment Index reached 61, its highest since May 2021, with 25% of producers viewing it as a good time for large investments.
Despite ongoing trade tensions and tariff concerns, 70% of farmers believe increased tariffs will benefit U.S. agriculture long-term. However, 56% expect negative impacts on 2025 farm income, and 53% anticipate input supply challenges. Farm equipment sales declined significantly in Q1 2025, with tractor sales dropping 19% and combine sales falling 38% year-over-year. The Farm Financial Performance Index remained stable at 101, while farmland value expectations weakened slightly.
CME Group (CME) achieved record-breaking performance in April 2025, with average daily volume (ADV) reaching an all-time high of 35.9 million contracts, up 36% year-over-year. Interest rate ADV surged 46% to 18.4 million contracts, while equity index and metals products set new monthly records. The company reported significant growth across multiple segments, with international ADV hitting a record 10.9 million contracts.
Notable achievements include record volumes in SOFR futures (6M contracts), Micro E-mini Nasdaq-100 futures (2.3M contracts), and U.S. Treasury options (1.8M contracts). Cryptocurrency ADV showed remarkable growth of 129%, while BrokerTec U.S. Repo ADNV increased 28% to $378 billion. Customer collateral balances for Q1 2025 stood at $78.6 billion in cash and $173.7 billion in non-cash.
CME Group has announced the launch of XRP futures on May 19, 2025, expanding its cryptocurrency derivatives suite. The offering will include both micro-sized (2,500 XRP) and larger-sized (50,000 XRP) contracts, cash-settled based on the CME CF XRP-Dollar Reference Rate.
The launch comes amid strong crypto trading performance, with Q1 highlights showing:
- Average daily volume of 198,000 contracts ($11.3 billion notional), up 141% year-over-year
- Average open interest of 251,000 contracts ($21.8 billion notional), up 83% year-over-year
- Over 43,000 SOL futures ($705 million notional) traded since March 17
Robinhood will offer these XRP futures to retail traders, while Teucrium's 2x Daily Long XRP ETF (XXRP) has already reached $35 million in AUM within its first 10 trading days, demonstrating strong investor demand for regulated XRP products.
CME Group, the world's leading derivatives marketplace, has announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division. Albuquerque, who brings over 20 years of industry experience, previously served as Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses.
Based in New York, Albuquerque will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. The appointment aims to strengthen the company's risk management services and clearing efficiencies for clients.
CME Group reported record financial results for Q1 2025, with revenue reaching $1.6 billion, up 10% from Q1 2024. The company achieved record average daily volume (ADV) of 29.8 million contracts, showing growth across all asset classes.
Key financial metrics include operating income of $1.1 billion, net income of $956 million, and diluted earnings per share of $2.62. On an adjusted basis, net income was $1.0 billion with diluted earnings per share of $2.80.
Notable performance highlights include:
- Commodities growth of 19%
- Financials increase of 12%
- ADV outside U.S. reached 8.8 million contracts, up 19% year-over-year
- Clearing and transaction fees revenue of $1.3 billion
- Market data revenue of $195 million
The company maintained strong liquidity with $1.6 billion in cash and paid approximately $2.6 billion in dividends during Q1 2025.
S&P Global (SPGI) and CME Group have announced the sale of their joint venture OSTTRA to KKR for $3.1 billion. The enterprise value will be split equally between both companies, as per their 50/50 ownership structure.
OSTTRA, established in 2021, provides post-trade solutions for the global OTC market across interest rates, FX, credit, and equity asset classes. The current management team, led by co-CEOs Guy Rowcliffe and John Stewart, will remain in their positions.
KKR plans to implement a broad-based equity ownership program for OSTTRA's 1,500 employees and will focus on increasing investments in technology and innovation. The transaction is expected to close in the second half of 2025, subject to regulatory approvals and customary closing conditions.
S&P Global and CME Group have announced the sale of OSTTRA to KKR for $3.1 billion. The transaction, expected to close in the second half of 2025, will split proceeds evenly between S&P Global and CME Group from their 50/50 joint venture.
OSTTRA, established in 2021, provides post-trade solutions for the global OTC market across interest rates, FX, credit, and equity asset classes. The current management team, led by co-CEOs Guy Rowcliffe and John Stewart, will remain in their positions.
KKR plans to implement a broad-based equity ownership program for OSTTRA's 1,500 employees and will focus on increasing investments in technology and innovation. The deal aims to enhance OSTTRA's market-leading post-trade solutions, drive innovation, and expand its global footprint.
CME Group achieved record international average daily volume (ADV) of 8.8 million contracts in Q1 2025, marking a 19% increase year-over-year. The growth was driven by strong performance across all asset classes, with notable records in EMEA (6.5M contracts, up 20%), APAC (2M contracts, up 20%), and Canada (196,000 contracts, up 17%).
International quarterly records were set in multiple product categories: Energy and Agricultural products both up 29%, and Foreign Exchange up 14%. Globally, CME Group reported a record quarterly ADV of 29.8 million contracts, representing a 13% year-over-year increase, with record volumes in Interest Rate, Equity Index, Agricultural, Foreign Exchange, and Cryptocurrency products.